Herbal Formula Science (대한한의학방제학회지)

The Korean Medicine Society for the Herbal Formula Study (대한한의학방제학회)
권호 표지
DOI QR코드

DOI QR Code

Remission of ulcerative colitis with severe diarrhea by herbal medicine treatment: A case report

한약으로 관해가 유도된 극심한 설사의 궤양성대장염 환자 증례보고

  • Lee, Byung-Hee (Hanstep Korean Medicine Clinic) ;
  • Won, Jiyoon (Department of Science in Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University) ;
  • Lee, Hyangsook (Department of Science in Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University)
  • 이병희 (한걸음한의원) ;
  • 원지윤 (경희대학교한의과대학대학원기초한의과학과) ;
  • 이향숙 (경희대학교한의과대학대학원기초한의과학과)
  • Received : 2021.05.10
  • Accepted : 2021.06.09
  • Published : 2021.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Ulcerative colitis (UC) is one of inflammatory bowel diseases (IBD) with unknown etiopathogenesis. This case report details remission of UC induced by Korean herbal medicine treatment. A 31-year-old male patient diagnosed as UC after a series of examinations including endoscopy and fecal calprotectin (FC) test. He had severe bloody diarrhea over 10-20 times a day despite taking 5-aminosalicylic acid and steroid. He was given individualized Korean herbal medicine Dowha-tang according to pattern identification. After taking Dowha-tang for 7 months, clinical remission was achieved. The symptoms disappeared and FC level went down to normal level. No adverse events were reported. This case report shows that Korean herbal medicine treatment may have the potential for clinical remission of UC. Further investigation is warranted.

Keywords

References

  1. Kwak MS, Cha JM, Lee HH, Choi YS, Seo SI, Ko KJ, et al. Emerging trends of inflammatory bowel disease in South Korea: A nationwide population-based study. J Gastroenterol Hepatol. 2019;34(6):1018-26. https://doi.org/10.1111/jgh.14542
  2. Langholz E. Current trends in inflammatory bowel disease: the natural history. Therap Adv Gastroenterol. 2010;3(2):77-86. https://doi.org/10.1177/1756283X10361304
  3. Menees S, Higgins P, Korsnes S, Elta G. Does colonoscopy cause increased ulcerative colitis symptoms? Inflamm Bowel Dis. 2007;13(1):12-8. https://doi.org/10.1002/ibd.20049
  4. Lim DS, Kim NU, Lee HH, Lee YS, Hong S, Kim HC, et al. One Case of Ulcerative Colitis Improved by Gagam-Sukhongjeon. Herbal Formula Science. 2007; 15(1): 229-37.
  5. Lee BH, Won JY, Lee HS. Herbal Medicine Treatment for Induction and Maintenance of Remission in Ulcerative Colitis: A Case Report. Korean J Acupunct. 2019; 36(3): 181-7. https://doi.org/10.14406/acu.2019.014
  6. Hwang JW, Choi HJ, Baik YS, Jeong SH, Shin GC, Lee WC. A Case of Pyungwijiyutang-gamibang Diagnosed as Constipation due to Stagnation of Eum with Ulcerative Colitis. The Journal of Internal Korean Medicine. 2007; 28(4): 972-7.
  7. Yoon SW. A Case Report of a Patient with Active Ulcerative Colitis Treated with Do-Che Decoctionbased Korean Medicine. Journal of Korean Traditional Oncology. 2012; 17(2): 17-22. https://doi.org/10.15432/JKTO.2012.17.2.017
  8. Hur JI, Cho DH, Son JY, Kwak MA, Kim DJ, Byun JS, et al. A Case Report of Ulcerative Colitis Medicated by Danggwihwahyeolsan-gamibang and Gami-Jeonssibaekchulsan. Herbal Formula Science. 2007; 15(2): 187-95.
  9. Seo CH, Lee HH, Choi KS, Lim DS, Ryu HC, Lee YS, et al. Two Cases of Ulcerative Colitis Diagnosed as Damp-Heat Dysentery Treated with Jakyaktanggamibang. The Journal of Internal Korean Medicine. 2006; 27(4): 984-90.
  10. Park SG, Kim GY, Shin SM, Ko H. Constitution Therapy of Adolescent Ulcerative Colitis: A Case Report. The Journal of Internal Korean Medicine. 2017; 38(4): 531-40. https://doi.org/10.22246/jikm.2017.38.4.531
  11. Kim SH, Kim HJ, Kim JE, Lee SH, Hong SH, Kim WI. Clinical Case of Symptoms Remaining after Western Medical Therapy in Ulcerative Colitis, with Herbal Medicine Dansamboheol-tang gagam, Acupuncture, and Moxibustion Treatment. The Journal of Internal Korean Medicine. 2007; 28(4): 911-8.
  12. Jang HJ, Sun JK, Sun TC. A Case Report of Chengsim Yeunja-Tang for Ankylosing Spondylitis associated with Severe Ulcerative Colitis. The Journal of Internal Korean Medicine. 2005; 26(3): 685-91.
  13. Martins NB, Peppercorn MA. Inflammatory bowel disease. Am J Manag Care. 2004;10(8):544-52.
  14. Curkovic I, Egbring M, Kullak-Ublick GA. Risks of inflammatory bowel disease treatment with glucocorticosteroids and aminosalicylates. Dig Dis. 2013;31(3-4):368-73. https://doi.org/10.1159/000354699
  15. Won JY, Lee BH, Jung WM, Chae YB, Lee HS. Herbal medicine for inflammatory bowel diseases: development of pattern identification algorithms by retrospective analysis of case series data. Eur J Integr Med. 2020; 36: 101114. https://doi.org/10.1016/j.eujim.2020.101114
  16. Lee BH. Herbal medicine for inflammatory bowel disease: systematic review and exploratory practice algorithm through case series. Korean Medicine. Seoul: Kyung Hee University. 2016: pp. 56-62.
  17. Gong QM, Wang SL, Gan C. [A clinical study on the treatment of acute upper digestive tract hemorrhage with wen-she decoction]. Zhong Xi Yi Jie He Za Zhi. 1989; 9(5): 272-3, 260.
  18. Yu Z, Zhang G, Dai Y, Kou J, Dou C, Lu R. [Pharmacological study on the compatibility of cortex Cinnamomi with Halloysitum Rubrum]. Zhongguo Zhong Yao Za Zhi. 1997; 22(5): 309-12 inside back cover.
  19. Nikkhah-Bodaghi M, Maleki I, Agah S, Hekmatdoost A. Zingiber officinale and oxidative stress in patients with ulcerative colitis: A randomized, placebo-controlled, clinical trial. Complement Ther Med. 2019;43:1-6. https://doi.org/10.1016/j.ctim.2018.12.021
  20. Rho EJ, Kang HE. Gobangryuchui. Seoul: Gobang. 2009.
  21. Knyazev OV, Kagramanova AV, Korneeva IA, Noskova KK, Belousov SV, Parfenov AI. The use of fecal calprotectin in monitoring activity of inflammatory bowel diseases. Ter Arkh. 2019;91(4):53-61.
  22. Ricciuto A, Griffiths AM. Clinical value of fecal calprotectin. Crit Rev Clin Lab Sci. 2019; 56(5): 307-20. https://doi.org/10.1080/10408363.2019.1619159
  23. Reenaers C, Bossuyt P, Hindryckx P, Vanpoucke H, Cremer A, Baert F. Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice. United European Gastroenterol J. 2018;6(8):1117-1125. https://doi.org/10.1177/2050640618784046
  24. Jusue V, Chaparro M, Gisbert JP. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease. Dig Liver Dis. 2018;50(4):353-9. https://doi.org/10.1016/j.dld.2017.12.022